Stuart Rich

CIK: 0001841785

Transaction Breakdown

Open Market Buys (P)5 (62.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TENX

TENAX THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

TENX
TENAX THERAPEUTICS, INC.
Jan 9, 2026
Award(A)
Stock Option (right to buy)
Direct
250K shares-
TENX
TENAX THERAPEUTICS, INC.
Dec 9, 2025
Purchase(P)
Direct
2.5K shares at avg. $10.22$26K
TENX
TENAX THERAPEUTICS, INC.
Dec 8, 2025
Purchase(P)
Indirect
2.5K shares at avg. $10.10$25K
TENX
TENAX THERAPEUTICS, INC.
Dec 4, 2025
Purchase(P)
Indirect
2.5K shares at avg. $9.20$23K
TENX
TENAX THERAPEUTICS, INC.
Dec 3, 2025
Purchase(P)
Direct
1.5K shares at avg. $9.08$14K
TENX
TENAX THERAPEUTICS, INC.
Dec 2, 2025
Purchase(P)
Direct
1K shares at avg. $9.01$9K
TENX
TENAX THERAPEUTICS, INC.
May 16, 2025
Award(A)
Stock Option (right to buy)
Direct
625K shares-
TENX
TENAX THERAPEUTICS, INC.
Dec 10, 2024
Award(A)
Stock Option (right to buy)
Direct
500K shares-

		Type	Shares	Price		Ownership
Jan 9, 2026	TENX TENAX THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	250,000	-	-	Direct
Dec 9, 2025	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	2,500	$10.22	$25,542	Direct
Dec 8, 2025	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	2,500	$10.10	$25,250	Indirect
Dec 4, 2025	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	2,500	$9.20	$22,998	Indirect
Dec 3, 2025	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	1,500	$9.08	$13,618	Direct
Dec 2, 2025	TENX TENAX THERAPEUTICS, INC.	Purchase(P)	1,000	$9.01	$9,006	Direct
May 16, 2025	TENX TENAX THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	625,000	-	-	Direct
Dec 10, 2024	TENX TENAX THERAPEUTICS, INC.	Award(A) Stock Option (right to buy)	500,000	-	-	Direct

1-8 of 8 transactions

About Rich Stuart

Rich Stuart (SEC CIK 0001841785) files insider reports with the SEC as Chief Medical Officer of TENAX THERAPEUTICS, INC. (TENX).

Signal8 holds 5 ownership filings by Rich Stuart, all Form 4s, filed between Dec 12, 2024 and Jan 13, 2026. Those filings report 8 transactions, from Dec 10, 2024 to Jan 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rich Stuart's filings is in CHAPEL HILL, NC.

Recent filings by Rich Stuart

Jan 9, 2026: Grant or award of TENX derivative securities (Form 4, code A).
Dec 9, 2025: Open-market purchase of TENX shares (Form 4, code P).
Dec 8, 2025: Open-market purchase of TENX shares (Form 4, code P).
Dec 4, 2025: Open-market purchase of TENX shares (Form 4, code P).
Dec 3, 2025: Open-market purchase of TENX shares (Form 4, code P).

Other insiders filing for TENAX THERAPEUTICS, INC. (TENX)

ADAR1 Capital Management, LLC, 10% Owner
Doogan Declan, Director
Giordano Christopher Thomas, CEO
STAAB THOMAS R II, Chief Financial Officer
MCGAULEY THOMAS, Interim CFO
Davidson Michael H., Director

How to read Form 4 transaction codes